Top 25 Biotechnology Companies in the World 2022

Top 25 Biotechnology Companies in the World 2022

Top 25 Biotechnology Companies in the World 2022

Top 25 Biotechnology Companies in the World 2022

What do biotech companies do?

Biotechnology is the use of discoveries in the life sciences to make things that can be sold. Therefore, a biotech life science company is a business that uses biotechnology to make products and provide services.

There are a lot of biotech companies all over the world. This article looks at some of the biggest biotech companies based on how much their stock is worth on the market.

The world's 25 biggest biotech companies

 

Johnson and Johnson

When you think of biotech companies, you probably do not think of Johnson & Johnson. Yet, the company is known as one of the biggest biotech companies in the world.

In 1886, Johnson & Johnson was started. It makes and sells more than 172 drugs in the U.S., some of which are well-known, like Tylenol and Sudafed.

Johnson & Johnson focuses on infectious diseases, oncology, immunology, and neuroscience when it comes to its pharmaceutical business.

Working for a company will change your life because you'll find new medical advances all the time. The company also has strict rules about quality.

In 2019, it was on the "LinkedIn Top Company" list, which shows the companies in the United States where the most people want to work.

According to the Johnson & Johnson website, it also made Fast Company's Top 10 lists of the most innovative biotech companies.

The organization is working on several intriguing developments, such as employing immunotherapy to treat cancer and vision problems.

Pfizer

Pfizer is the second biggest pharmaceutical company in the world in terms of biotechnology. It was started in 1849 as a chemical company. In the 1880s, when it started making and selling citric acid, it grew a lot.

Today, Pfizer is a global pharmaceutical company that focuses on vaccines and medicines for a wide range of health fields, such as oncology, immunology, diabetology, neurology, and cardiology.

Celebrex and Lipitor are two of its most well-known brands. Its research headquarters are in Groton, in the US state of Connecticut, and its corporate headquarters are in New York City.

This company has about 78,300 employees and made $48.85 billion in sales in 2015. In 2016, the value of Pfizer on the stock market was $196 billion.

AstraZeneca plc

AstraZeneca plc is a leading multinational pharmaceutical and biotechnology company with its headquarters in Cambridge, United Kingdom.

Its focus is on finding and making new prescription medicines. In April 2020, AstraZeneca and the University of Oxford announced that they would work together to make the COVID-19 vaccine and get it to people.

Novo Nordisk A/S (NVO)

Novo Nordisk is Danish multinational biotechnology and biomedical corporation with production sites in seven countries and affiliates or offices in eighty countries.

Diabetes treatment, hemophilia care, growth hormone therapy, and hormone replacement therapy are the company's core focuses.

The company manufactures a variety of medications under a variety of brand names, including Levemir, NovoLog, Novolin R, NovoSeven, NovoEight, and Victoza.

Aduro Biotech

Aduro is a clinical-stage biopharmaceutical startup based in California.

It focuses on discovering, developing, and commercializing medical medicines that utilize the body's natural immune system to cure illness, particularly in cases involving more difficult disorders.

The company's annual revenue is between $50 and $100 million (USD).

Glass Door notes that corporate employees have described a collegial work environment and an emphasis on encouraging one another.

Aduro Biotech is a company to consider if you wish to advance and flourish in the biotechnology industry, as there are numerous employment options available.

Aduro Biotech is a company to examine, not just because of its workplace policies, but also because it currently has numerous medications in Phase 1 and 2 trials that are certain to create waves shortly.

These candidates utilize Aduro's STING Pathway Activators and B-select monoclonal antibody technology to stimulate or regulate immune responses within the body.

For a number of these, Aduro has teamed with Merck, one of the world's major pharmaceutical corporations.

Novartis

 

Novartis is a Swiss-based organization. It was founded in 1996 following the merging of Sandoz and Ciba-Geigy. Its primary focus is on pharmaceuticals, generic medicines, and eye care.

Novartis's efforts to expand into emerging countries, including Africa and Latin America, make it a wonderful place to work if you want to make a difference in the health of people who have been underrepresented in the past.

It currently exports goods to 155 countries and focuses on diversification.

Novartis is regarded as one of the top biotechnology corporations. It ranks fourth on Fortune's ranking of the pharmaceutical industry's "Most Admired Companies."

According to reviews on Glass Door, the organization provides an excellent opportunity for graduates to learn about pharmaceuticals and the technical side of the work.

Alexion Pharmaceuticals Inc.

Alexion is a biopharmaceutical firm that develops and sells immunoregulatory medications to treat cardiovascular and autoimmune illnesses.

Alexion's pharmacological therapies aim to give patients with medicines that selectively target immune system components that may contribute to the spread of disease.

Vertex Pharmaceuticals Inc.

Vertex is a biopharmaceutical business that focuses on developing and marketing therapies for a variety of diseases, including cancer, cystic fibrosis, autoimmune diseases, and neurological disorders.

Merck & Company

Merck & Co. is an American pharmaceutical and biotechnology firm headquartered in Rahway, New Jersey that offers a variety of innovative health solutions, such as prescription medications, biologic therapies, vaccines, and animal health products, among others.

Merck announced in June 2022 the opening of Merck Digital Science Studio (MDSS), a cooperation between Merck and the New Jersey Innovation Institute (NJII) that would enable the creation of breakthrough technologies for medication research.

Jazz Pharmaceuticals PLC (JAZZ)

Jazz Pharmaceuticals is an Irish biopharmaceutical company that makes and sells drugs for narcolepsy, psychiatry, pain management, and oncology.

On March 25, the company announced that the Food and Drug Administration (FDA) had approved its drug JZP-258 to treat cataplexy, which is when you fall asleep during the day.

SQZ Biotechnologies Co.

The SQZ Biotechnologies Company's main goal is to make cell therapies that can be used to treat a wide range of diseases. SQZ Cell Therapy Platform is something that the company, which is based in Michigan, has made.

It breaks down cell membranes to get healing substances into the cells of the body. This lets doctors treat diseases in ways that were not possible before.

Some employees of the company have said on Glass Door that the company is always growing, which gives them room to move up in their careers and gives everyone a lot of work.

The company is also said to have a work culture that puts the patient first.Other workers have said that the company is fun to work for, for example, because it has smart people and cool technology.

About $17.1 million is thought to be how much SQZ Biotechnology makes each year.

Amgen, Inc

Amgen is a biopharmaceutical company that has been around since 1980 and has its headquarters in Thousand Oaks, California. It is thought to be one of the largest independent biotech companies in the world.

Its focus is on biology, and it uses the latest science and technology to study biological mechanisms and find treatments that can help people with serious diseases live better lives.

The company focuses on six therapeutic areas: cancer, heart disease, brain health, inflammation, kidney health, and bone health.

Amgen is in about 100 countries and regions around the world and millions of people have used their innovative drugs. Forbes Magazine and Just Capital named Amgen one of the "Just 100" companies in 2020.

This list ranks companies based on their priorities and important issues that define fair and ethical business behavior.

The company makes almost $23 billion in sales every year and employs about 19,000 people around the world.

Amgen has a portfolio of drugs that make money. Some of the best are Enbrel, which treats rheumatoid arthritis, and Neulasta, which prevents infections caused by chemotherapy.

In 2018, the Aimovig drug, which was made by Amgen and Novartis, was approved by the Federal Drug Administration (FDA).

It is the first drug that the FDA has approved to prevent migraines. Fast Company says that it is in a group of medicines that use engineered antibodies to target protein receptors.

Glass Door says that Amgen employees have great leadership, good benefits, and many chances to grow in their field. Health, dental, and vision insurance are all examples of employee benefits.

Biomarin Pharmaceutical Inc. (BMRN)

Biomarin Pharmaceutical Inc. (BMRN) The Company also offers diagnostic and analytical services for applications in carbohydrate biology.

United Therapeutics Corp. (UTHR)

United Therapeutics makes most of its drugs to treat pulmonary hypertension, peripheral vascular disease, and other problems with the blood vessels.

Remodulin, Orenitram, Unituxin, and Tyvaso are some of the most popular medicines made by the company.

Alkermes PLC (ALKS)

Alkermes is an Irish company that makes medicines. This company makes medicines for problems with the central nervous system, like depression, schizophrenia, and addiction. It also talks about how to treat diabetes.

Ionis Pharmaceuticals Inc. (IONS)

It also talks about how to treat diabetes. Ionis Pharmaceuticals Inc. (IONS) is a biotechnology company that finds and creates medicines based on RNA.

Its three main medicines that are sold commercially are WAYLIVRA, Spinraza, and Teased. It is also making drugs to treat Huntington's disease, ALS, and heart disease. These medications are in various phases of development.

North Carolina Biotechnology Center

The North Carolina General Assembly helps fund the North Carolina Biotechnology Center, which is a non-profit business.

It wants to change North Carolina's economy, which is based on life science and technology, and one way it plans to do this is through innovation.

Through commercialization, innovation, business growth, and education, it also works to speed up technology-based economic development. Pfizer pays for it.

Even though the center doesn't do its research, it helps the government, universities, and different industries work together to develop technology and create jobs.

It wants to improve education so that people can get ready for jobs in biotech and help companies that are making a difference in the field.

People who have worked at N.C. The Biotechnology Center has said in Glass Door reviews that they like how the company gives them a good balance between work and life and that the workplace is full of individuals with a desire to make a difference.

Regeneron Pharmaceuticals

Great Place to Work did a study and found that 88 percent of current Regeneron Pharmaceuticals employees think it's a great company to work for.

Physician-scientists who are passionate about using science to improve people’s health lead Regeneron.

The company works in the biotechnology and pharmaceutical industries. Regeneron has been able to get a lot of medicines approved by the FDA so far.

Regeneron is also working hard to stop COVID-19. The company has found two antibodies that might be able to fight the virus.

By putting them together to make REGN-COV2, an antibody solution, there is hope that this will help treat the virus and keep healthy people from getting it.

Motley Fool has said that this would mean that a vaccine and a treatment wouldn't have to be made separately. This could be a huge step forward for human health.

There is significant expansion inside the company.  It made $1.8 billion in the first quarter of 2020, which is a 33 percent increase from the same time last year.

Putting them together to make REGN-COV2, an antibody solution, there is hope that this will help treat the virus and keep healthy people from getting it.

The Motley Fool has said that this would mean that a vaccine and a treatment wouldn't have to be made separately. This could be a huge step forward for human health.

There is a lot of growth in the company. It made $1.8 billion in the first quarter of 2020, which is a 33 percent increase from the same time last year.

Kite Pharma

This biotech company's main goal is to find a cure for cancer, which is one of the most dangerous diseases that need a cure as soon as possible.

The National Cancer Institute says that 606,520 Americans are expected to die from cancer in 2020 alone.

How does Kite Pharma plan to find a treatment for this disease that kills so many people?

By using immune cells that have been changed genetically so that they can be told to find and attack tumors in the body.

The way cancer is treated will change and get better because of this.

Because it does such important medical research, working at this biotech company is sure to get you excited.

Kite Pharma makes between $10 million and $25 million a year, but this is going to go up now that the FDA has approved Tecartus, which is the first CAR-T cell therapy approved to treat mantle cell lymphoma, a slow-growing form of non-lymphoma.

Hodgkin's CAR-T cell therapy is a way to make a person's T cells, which are part of the immune system, attack and kill cancer cells. This is done in a lab.

Gilead Sciences, Inc.

Gilead Sciences, Inc., a well-known biotechnology company, bought Kite Pharma a few years ago. This will help Kite Pharma continue to grow in the years to come.

Genentech

Genentech, a California-based company, was named number one on Fortune's list of the best biotechnology company workplaces.

People have praised the company for having a diverse and inclusive workforce and giving employees chances to grow within the company.

In 2009, Roche bought Genentech, a biotechnology company. Its main goal is to find new ways to treat illnesses.

So far, the company has found the first targeted antibody to treat cancer and the first drug to treat primary progressive multiple sclerosis.

The company gives its workers a lot of competitive benefits, like health insurance that covers dental and vision care.

Even people who only work part-time get health insurance. There are also many resources for employees, like mindfulness tools, training in resiliency, mental health therapy sessions, and fitness apps.

Sanofi

This well-known French biopharmaceutical company often makes lists like Proclinical's "Top 10 pharmaceutical companies in the world."

Sanofi focuses on medical research, such as vaccines, heart health, cancer research, and more. One of the three companies that give insulin to people with diabetes is Sanofi.

People have said good things about the company's benefits and pay, and 77 percent of its employees have told Glass Door that they would recommend the company to other people.

Sanofi is doing important work during the COVID-19 pandemic, just like other biotech companies. It recently agreed with GlaxoSmithKline (GSK) to give the UK 60 million doses of the COVID-19 vaccine as soon as it is ready.

It is also speeding up its clinical trials so that it can get a vaccine out on the market much more quickly. Stat News says that the vaccine that the company is developing with GSK will now start its Phase 1 and 2 clinical trials in September 2020 instead of December 2020.

Roche Holding AG

Roche, which started in 1896 as a company that sold vitamins, is the third largest biotech company in the world.

It was the first company in the world to make large quantities of vitamin C made from chemicals. Now a global company makes pharmaceuticals and medical tests.

Roche products include Valium, Bactrim, Avastin, and Naprosyn, some of the best-known Roche products.

Its main office is in Switzerland, in the city of Basel. Roche has bought several biotech companies over the years.

In January 2016, it was announced that Tensha Therapeutics had been bought for $115 million. This company has about 88,509 employees and made $47.65 billion in sales in 2014. In 2016, Roche was worth $192.1 billion on the stock market.

Biogen

Biogen has been in the news for its recent growth. In the last year alone, the company made about $10 billion.

This Massachusetts-based biotech company has also been in the news a lot because of the drugs it has made.

CNBC reports that it has recently been predicted that Biogen's stock will go up by 30 percent over the next year. What are investors told to do?

Own Biogen stock and get long-term benefits from it. This is mostly because of the company's new drug for Alzheimer's.

This experimental drug, called aducanumab, is the first possible treatment for Alzheimer's disease that could change the way the disease works.

Abbott Laboratories

Abbott Laboratories is an international healthcare and pharmaceutical company based in the United States.

Abbott is in more than 150 countries around the world. Abbott's most important areas of work involve diabetes, diagnostics, neuromodulation, nutrition, and pharmaceuticals.

As of 2021, more than 113,000 people work for them. The head office is in the USA.

Get The CEO Magazine to your Door Steps; Subscribe Now

Related Stories

No stories found.
The CEO Magazine India
www.theceo.in